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Abstract   
Objective: Emerging evidence has suggested that adventitia stem/progenitor cells 
(AdSPCs) migrate into the intima of arteries in response to injury, where they 
differentiate toward smooth muscle cells (SMCs) and participate in neointimal 
hyperplasia. We have previously identified matrix metalloproteinase-8 (MMP8) as a 
key player in atherogenesis. In this study, we aimed to investigate the functional roles 
of macrophage-derived MMP8 in AdSPC differentiation and injury-induced arterial 
remodelling. 
Methods and Results: We first observed an important role for MMP8 in SMC 
differentiation from embryonic stem cells, but this effect was not seen in AdSPCs. 
Instead, through macrophages/AdSPCs co-culture and macrophage conditional 
culture medium studies we have demonstrated that the MMP8 protein secreted from 
macrophages promotes SMC differentiation from AdSPCs. Mechanistically, we 
showed that macrophage-derived MMP8 promotes SMC differentiation from AdSPCs 
through modulating TGF-β activity and a disintegrin and metalloproteinase 
domain-containing protein 10 (ADAM10)/Notch1 signaling. We further demonstrated 
that the binding site for CBF1, Suppressor of Hairless, and Lag-1 (CSL) within SMC 
gene promoters is responsible for Notch1 mediated SMC differentiation. Finally, we 
demonstrated that macrophage-derived MMP8 increased injury-induced neointimal 
SMC hyperplasia by activating ADAM10/Notch1 signaling.  
Conclusions: We have identified macrophage-derived MMP8 as a regulator in SMC 
differentiation from AdSPCs and neointimal SMC hyperplasia in response to injury. 
Our data provides new insights into the roles of MMP8 in AdSPC differentiation and 
the pathogenesis of neointima formation in the context of angiographic restenosis, 
and therefore may aid in the development of novel therapeutic agents for the 
prevention of this disease. 
 
Key Words: Adventitia stem cells; Progenitor cells,  Arterial remodelling; Neointima 
formation; Atherosclerosis; Matrix metalloproteinase-8; smooth muscle cell 
differentiation, Notch signalling;  A disintegrin and metalloproteinase 
domain-containing protein 10 
 
Abbreviations: SMC, smooth muscle cell; AdSPCs, adventitia stem/progenitor cells; 
MSCs, mesenchymal stem cells; EC, endothelial cell; ES cells, embryonic stem cells; 
MMP8, matrix metalloproteinase-8; ADAM10, a disintegrin and metalloproteinase 
domain-containing protein 10; NICD, intracellular domain of the notch protein; CSL, 
CBF1, Suppressor of Hairless, and Lag-1; Sox, SRY-related HMG-box; TGF-β, 
transforming growth factor-β; Sca-1, stem cell antigen-1; qRT-PCR, quantitative 
reverse transcription polymerase chain reaction; shRNA, short hairpin RNA; CHIP, 
chromatin immunoprecipitation; SMαA, smooth muscle alpha-actin; SM22α, smooth 
muscle 22 alpha; SM-MHC, smooth muscle myosin heavy chain; SM-myh11, smooth 
muscle myosin-11; SRF, serum response factor; Myocd, myocardin; MEF2c, myocyte 
enhancer factor 2C. 
CVR-2018-1022_Author Accepted Version 
 3 
Introduction 
Accumulating evidence has suggested that blood vessels throughout the body serve 
as a systemic reservoir of multipotent stem/progenitor cells (SPCs). Recently, a 
variety of SPCs have been identified that are both anatomically and functionally 
associated with adventitia/perivascular niches in various tissues, including adventitial 
SPCs (AdSPCs) 1-9. Moreover, their contributions to vascular regeneration10, 
development, homeostasis, health as well as diseases2, 7, 8, 11-16 has been gradually 
recognized and appreciated in the field of vascular biology. These AdSPCs, identified 
through distinct panels of cell markers, such as stem cell antigen-1 (Sca-1)2, 3, 7, 
CD344, 17-19, vascular endothelial growth-factor receptor 2 (VEGFR2)/stem cell 
antigen c-Kit20, PW121, Gli122, CD9023, mesenchymal stem cell (MSC) markers (CD29, 
CD44, CD73, CD105, CD146, and/or CD166)24-26, as well as one or more MSC 
markers in combination with neural crest (e.g., Sox1, Sox10, Sox17 and Nestin)8, 
pericyte progenitor (NG2 and platelet-derived growth factor receptorβ1) or other stem 
(e.g., Stro-1, Notch-1, and Oct-4)17, 27 cell markers, are capable of differentiating into 
smooth muscle cells (SMCs), neural cells, chondrocytes, adipocytes, and/or 
osteoblasts. It has also been reported that the AdSPCs that are positive for Sca-128, 29, 
CD3417-19, or VEGFR2/c-Kit20, but not for other stem cell markers, have the ability to 
differentiate towards endothelial cells (ECs), albeit to a lesser extent. Although the 
cellular origins of these AdSPCs remains to be elucidated, an elegant study has 
suggested some of them origin from the differentiated SMCs in the media30. 
Pathologically, these local residential AdSPCs have been suggested as one of the 
main cellular sources for neointima cells including SMCs during arterial remodeling in 
response to mechanical injury1, 8, vascular grafting2, 7, 25, 31, or acute/chronic 
inflammation13, through their differentiation into SMCs or SMC-like cells in intima. 
Despite several signaling pathways including integrin/collagen IV axis2, 
EGFR/ERK1/2/β-catenin29, c-Myb/myocardin32, CXCR422, and DKK3 (dickkopf 
3)/TGF-β (transforming growth factor-β)/ATF6/Wnt signaling33 have been implicated 
in SMC differentiation from these AdSPCs, a detailed description of how these 
AdSPCs are driven to differentiate into SMCs in intima is currently incomplete. 
 
Matrix metalloproteinase-8 (MMP8), also known as collagenase-2, has potent 
proteolytic activity on matrix proteins such as fibrillar collagens, laminin, fibronectin34 
and fibromodulin35, as well as a variety of other proteins (e.g., chemokines CXCL536 
and CXCL1137, Angiotensin I (Ang I)38, A Disintegrin and metalloproteinase 
domain-containing protein 10 (ADAM10)39, 40, and transforming growth factor-β 
(TGF-β)35 ). Compelling evidence has suggested a role for MMP8 in the pathogenesis 
of atherosclerosis and related cardiovascular conditions such as myocardial infarction, 
heart failure, neointima formation following angioplasty, and abdominal aortic 
aneurysm41. Specifically, previous studies have shown that macrophages, SMCs, 
ECs42 and bone marrow-derived SPCs40 in atherosclerotic lesions express MMP8. 
Moreover, increased intraplaque MMP-8 levels are associated with carotid plaque 
progression lesion progression in asymptomatic patients43, and raised plasma MMP8 
levels are an independent predictor for cardiovascular mortality in men44, highlighting 
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a role for MMP8 in atherosclerosis and cardiovascular diseases. Indeed, by 
generating MMP8-deficient mice we are the first to confirm a causal role for MMP8 in 
the pathogenesis of atherosclerosis38. Importantly, we observed less SMC content 
within atherosclerotic plaques38 and vascular injury-induced neointima39 in 
MMP8-deficient mice, which may result from a lower level of SMC proliferation and 
migration from media, an impaired migratory ability of SPCs, and/or decreased 
capacity of the SPCs to differentiate into SMCs. We have recently proved that MMP8 
gene deficiency results in decreased SMC migration and proliferation39, and 
MMP8-deficient SPCs exhibit an impaired ability to migrate into intima40. However, 
the importance of MMP8 in SMC differentiation from AdSPCs remains to be explored. 
In this study, we examined the functional importance of MMP8 in SMC differentiation 
from AdSPCs, and further elucidated the molecular mechanisms involved. 
 
Methods & Materials 
 
Materials and Data Availability 
The data that support the findings of this study are available from the corresponding 
author upon reasonable request. 
 
Cell isolation, culture and treatments  
The procedures for mouse aortic adventitia stem/progenitor cell (AdSPC) isolation 
and culture were similar to the protocols described in the previous study8, 45 with slight 
modifications. Briefly, mice (25-30 grams) were euthanized by CO2 and the thoracic 
aortas were dissected to remove the surrounding connective tissues. Aortas were 
washed three times with PBS supplemented with 1% penicillin/streptomycin (P/S), 
and incubated in collagenase I for 15 min. Adventitia were carefully dissected away 
under a dissecting microscope, and cut into 1-2 mm size. Tissue blocks from 10 mice 
were pooled together and incubated with 3 mg/ml type II collagenase in DMEM with a 
1/5 (w/v) ratio of tissue (g) to enzyme solution (ml). After incubation for 30 min, the 
same volume of 1 mg/ml elastase solution was added to the solution containing the 
tissue and collagenase. The tissues were incubated for another 1–2 h until all the 
tissues were digested. After filtering with a Cell Strainer (70µm), single cell digestion 
solution was centrifuged to remove the digestion solution. Cells were re-suspended in 
AdSPC maintenance medium (DMEM with 2% chick embryo extract, 1% FBS, 1% N2, 
2% B27, 100 nM retinoic acid, 50 nM 2-mercaptoethanol, 1% P/S and 20 ng/ml bFGF) 
and transferred to six-well culture plate pre-coated with 1% CellStart (Invitrogen, 
A1014201). AdSPCs were maintained in the same medium for up to 10 passages. 
Every batch of AdSPCs at passage 3 was tested by AdSPC marker Sox10 and Nestin 
staining to ensure the purity of primary AdSPCs above 95%.  
 
Detailed protocol for bone marrow-derived macrophage (BMM) culture was described 
in our previous study35. MagCellect™ Mouse Hematopoietic Cell Lineage Depletion 
Kit (MAGM209, R&D System) was used to isolate bone marrow SPCs (BM_SPCs) 
according to the manufacturer's instructions as described in our previous study40.  
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Three protocols were used for SMC differentiation from AdSPCs:  
TGF-β1 protocol: Undifferentiated AdSPCs (p3~p10) were cultured in SMC 
differentiation induction medium (DMEM supplemented with 5% FBS and 5ng/ml 
TGF-β) for 2 to 6 days. The medium was refreshed every other day. 
BMM co-culturing system: Freshly prepared BMMs were co-cultured with AdSPCs 
(p3~p10) (1:1) in DMEM supplemented with 5% FBS for 2 to 6 days. The medium 
was refreshed every other day. 
BMM conditional culture medium: Undifferentiated AdSPCs (p3~p10) were 
cultured in BMM conditional culture medium (CM) for 2 to 6 days. The CM was 
refreshed every day. 
 
SMC gene promoters and CSL mutants  
SMC gene promoters (pGL3-SMαA/SM22α-WT)46 and their corresponding serum 
response factor (SRF) binding site mutants (pGL3-SMαA/SM22α-SRFmut)47 were 
generated in our previous studies. CSL binding site mutation was introduced into 
pGL3-SMαA/SM22α-WT plasmids by using QuikChange™ site-directed mutagenesis 
kit (Agilent Technologies) according to the manufacturer's instructions, and 
designated as pGL3-SMαA/SM22α-CSLmut. All vectors were verified by DNA 
sequencing. 
 
Animal experiments, anaesthesia and euthanasia 
All animal experiments were conducted according to the Animals (Scientific 
Procedures) Act of 1986 (United Kingdom). All the animal procedures were approved 
by Queen Mary University of London ethics review board (PPL number: 70/7216), 
and conform to the guidelines from Directive 2010/63/EU of the European Parliament 
on the protection of animals used for scientific purposes or the NIH guidelines (Guide 
for the care and use of laboratory animals). For mouse carotid artery denudation 
injury and macrophage transplantation, anaesthesia was induced using 100% O2/4% 
isoflurane, and was maintained throughout the procedure by the administration of 
100% O2/2% isoflurane. At the end of protocol, all mice were euthanized by placing 
them under deep anaesthesia with 100% O2/5% isoflurane, followed by decapitation. 
 
Mouse carotid artery denudation injury and perivascular transplantation of 
macrophages  
MMP8_KO mice on apolipoprotein E-/-/C57BL/6 genetic background were generated 
in our previous studies38-40. The surgical procedure for carotid artery denudation 
injury was performed as previously described39, 48, 49. Removal of the endothelium of 
the left common carotid artery was achieved by 3~5 passages of a 0.38 mm curved 
flexible wire (Reference Part Number: C-SF-15-20, Cook Medical European Shared 
Services, Ireland). After the vascular injury, the injured carotid arteries were randomly 
embedded with Matrigel containing vehicle, WT or MMP8_KO bone marrow-derived 
macrophages (BMMs). Briefly, immediately after injury, 100µl Matrigel mixed with 
20µl of cell culture medium containing 1x106 WT or MMP8_KO BMMs or culture 
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medium alone (vehicle) was applied perivascularly to injured carotid arteries. At day 3, 
14 and 28 post-injury, the injured carotid arteries were harvested for gene expression, 
immunofluorescence staining, and morphometric analysis, respectively. For gene 
expression assay, 3~5 injured carotid femoral arteries (~5.0 mm) from each group 
were pooled for each independent experiment to ensure good quality of RNA 
samples. All animal experiments were performed according to protocols approved by 
the Institutional Committee for Use and Care of Laboratory Animals. 
 
Statistical analysis. Results are presented as mean ± standard error of the mean 
(SEM). Statistical analysis was performed using Graphpad Prism5. Shapiro-Wilk 
Normality Test was used for checking the normality of the data. Two tailed unpaired 
student’s t-test was used for comparisons between 2 groups, or one-way analysis of 
variance with a post hoc test of LSD was applied when more than two groups were 
compared if the data display a normal distribution. Conversely, non-parametric 
Mann-Whitney U Test or Kruskal–Wallis H test was applied for comparing two groups 
and three or more groups, respectively, if the data did not display normal distribution 
or if the number of observations from each group was smaller than 5 (n<5). 
Alpha=0.05 was chosen as the significance level, and a value of P < 0.05 was 
considered as statistically significant. 
 
Additional materials and methods used in this study are described in detail in 
the Online Supplement, include bone marrow-derived macrophage (BMM) culture; 
SMC differentiation from embryonic stem (ES) cells; shRNA lentiviral infection or 
siRNA transfection; Plasmid transient transfection and luciferase assay; Real time 
quantitative PCR (RT-qPCR); Immunoblotting; Indirect immunofluorescent staining for 
cells; Chromatin immunoprecipitation (ChIP) assays; Morphometric analysis, 
quantification of lesion formation, and tissue immunofluorescence staining.  
 
Results 
 
MMP8 plays an important role in SMC differentiation from ES cells 
We have previously established a simple but efficient approach to derive SMCs from 
ES cells50, and extensively proven that this model provides a powerful platform for us 
to uncover the potential important regulators governing SMC differentiation. To study 
the potential involvement of MMP8 in this model, we first detected if MMP8 
expression is altered during SMC differentiation from ES cells. Indeed, both gene 
(Figures S1A) and protein (Figures S1B) expression levels of MMP8 were 
significantly up-regulated from day 2 of differentiation and maintained at a higher 
expression level over the 8-day differentiation period compared to that of the 
undifferentiated (day 0) ES cells. Interestingly, such up-regulation appears to precede 
SMC-related protein expression, inferring an involvement for MMP8 in SMC 
differentiation from ES cells (Figures S1A & S1B). Importantly, all four SMC 
differentiation genes were significantly down-regulated by MMP8 gene knockdown 
(Figures S1C & S1D), confirming an essential role for MMP8 in SMC differentiation 
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from ES cells.   
 
No significant difference was observed in SMC differentiation from control and 
MMP8-deficient AdSPCs  
It worth mentioning that our ES-SMC differentiation model is an excellent platform to 
study SMC differentiation and maturation during embryonic development, but it is not 
bear close relevance to SMC differentiation in vascular disease and their contribution 
to vascular injury-induced restenosis. To establish such a disease-related SMC 
differentiation model, we first isolated and characterized AdSPCs using a previously 
reported protocol with modifications8, 45. Double immunofluorescent staining 
confirmed that these AdSPCs were strongly stained positive for the reported stem cell 
markers including Sox1, Sox10, Sox17 and Nestin, but negative for CD45 (leukocyte), 
fibroblast-specific protein 1 (FSP1) (fibroblast), smooth muscle myosin heavy chain 
(SM-MHC) (SMC) and CD31 (EC) (Figures S2A-S2D). RT-qPCR data showed that 
the AdSPCs could be maintained in vitro for a long period (up to 10 passages, P10) 
without apparent change of gene expression. However, a decreased and increased 
expression for stem cell marker genes and SMC genes was observed in AdSPCs at 
later stage (P12), respectively (Figures S2E). Therefore, AdSPCs between P3 and 
P10 were used in this study. Importantly, when cultured in stem cell culture medium, 
these AdSPCs could maintain a high expression level of the abovementioned stem 
cell markers with a very low expression level or even absence of SMC markers 
(SMαA and SM-MHC). However, when they were incubated with SMC differentiation 
medium containing 5ng/ml TGF-β1, we observed a significant increase in SMC 
markers at both RNA (Figures 1A) and protein (Figures 1B) levels. Similarly, the 
gene expression of SMC differentiation transcription factor, serum response factor 
(SRF) and its co-activator Myocardin, were also significantly increased during SMC 
differentiation from AdSPCs, along with another SMC differentiation regulator, 
myocyte enhancer factor 2C (MEF2C) (Figures 1C). As expected, both Sox10 and 
Sox17 gene expression were dramatically down-regulated over the 6-day 
differentiation period (Figures 1D), further confirming SMC differentiation from 
AdSPCs.   
 
Unlike the finding from ES-SMC differentiation model, we unexpectedly observed a 
slight increased MMP8 expression at both RNA (Figures 1A) and protein level 
(Figures 1B) at a very late SMC differentiation stage (day 6). To investigate whether 
MMP8 played a role in AdSPCs differentiation toward SMCs, we isolated AdSPCs 
from both MMP8 knockout (MMP8_KO) mice and their wildtype (WT) control 
littermates and compared their ability to differentiate into SMCs. Surprisingly, we 
found no significant effect of MMP8 gene inactivation on SMC differentiation from 
AdSPCs (Figure S3). This unexpected observation prompted us to examine the 
expression levels of MMP8 in these AdSPCs. Indeed, data from RT-qPCR (Figure 
S4A) and Western blot (Figure S4B) analysis showed that while ES cells, ES 
cell-derived SMCs, as well as bone marrow-derived macrophages (BMMs) and 
BM-derived SPCs (BM_SPCs) isolated from WT mice exhibited varying degrees of 
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MMP8 expression at both the RNA and protein levels, AdSPCs isolated from WT 
mice expressed little MMP8. On the other hand, BMMs, BM-derived SPCs and 
AdSPCs isolated from MMP8_KO mice expressed no MMP8, further validating 
MMP8 gene knockout in these cells. Taken together, the above data demonstrated 
that unlike BM-derived SPCs, AdSPCs express very little or no MMP8, while 
AdSPC-derived SMCs express MMP8 at later stage, albeit to a very low level. 
MMP8_KO AdSPCs were used in the rest of experiments to study the effect of 
macrophage-derived MMP8 on SMC differentiation from AdSPCs to minimalize the 
experimental variation and avoid potential influence of AdSPC-derived MMP8 on 
SMC differentiation. 
 
The secretory molecules from macrophages are responsible for SMC 
differentiation from AdSPCs 
As mentioned previously, macrophages are a major cellular source of MMP8 within 
atherosclerotic plaques. Indeed, a previous study showed that macrophages control 
SMC differentiation from human adipose tissue–derived MSCs51. Moreover, the 
following points prompted us to hypothesize that macrophage-derived MMP8 plays 
an important role in the regulation of SMC differentiation from AdSPCs. 1) AdSPCs 
belong to MSC family within arteries; 2) they express a similar pattern of cell markers 
to adipose tissue–derived MSCs; and 3) importantly, as we have previously shown, 
MMP8 plays a critical role in the regulation of TGF-β1 production from macrophages, 
its bioavailability and biological activity35. To begin with, we first examined whether 
macrophages can control SMC differentiation. Our data revealed that co-culturing of 
macrophages with AdSPCs significantly promotes AdSPC differentiation towards 
SMCs as evidenced by an increased expression of SMC-related genes at both RNA 
and protein levels (Figure S5A & S5B), and decreased expression levels of Sox10 
and Sox17 (Figure S5C). To investigate whether these findings are a result of direct, 
cell-to-cell interactions between macrophages and AdSPCs, or due to paracrine 
effects of macrophages, the culture medium of macrophages was collected and used. 
Following incubation of AdSPCs with macrophage culture medium, we observed a 
similar degree of SMC differentiation of AdSPCs to what has been described above 
(Figure S6), suggesting that secreted signals released by macrophages can induce 
SMC differentiation from AdSPCs.  
 
Macrophage-derived MMP8 plays an important role in SMC differentiation from 
AdSPCs 
Having determined that macrophage co-culture or conditioned culture medium can 
induce SMC differentiation from AdSPCs, we examined whether macrophage-derived 
MMP8 played a role in AdSPC differentiation towards SMCs. Incubation of 
MMP8_KO AdSPCs with macrophages isolated from MMP8_KO mice resulted in 
significantly decreased SMC marker expression in AdSPC, compared to AdSPCs 
incubated with macrophages from WT mice (Figure 2A-2C). A similar phenomenon 
was observed when MMP8_KO AdPSCs were incubated with the culture medium 
taken from MMP8_KO macrophages (Figure 2D-2F). This data demonstrates that 
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macrophage-derived MMP8 plays an important role in promoting SMC differentiation 
from AdSPCs through a paracrine route. 
To further examine the effects of MMP8 in the macrophage conditioned culture 
medium on AdSPC differentiation towards SMCs, the WT macrophage conditioned 
culture medium was incubated with an MMP8 neutralizing antibody prior to using in 
SMC differentiation. We observed a significant decrease of SMC gene expression in 
AdSPCs when they were cultured in the WT macrophage conditioned culture medium 
depleted of MMP8 protein (Figure 2G). Conversely, addition of exogenous activated 
MMP8 into the culture medium conditioned by MMP8_KO macrophages could 
dramatically promote SMC differentiation from AdSPCs (Figure 2H), further 
confirming an important role for macrophage-derived MMP8 in SMC differentiation 
from AdSPCs.        
 
TGF-β activated by macrophage-derived MMP8 promotes SMC differentiation 
from AdSPCs 
Since we have previously demonstrated that TGF-β1 production, as well as its 
bioavailability and biological activity in macrophages is regulated by MMP835, and 
TGF-β1 is a powerful inducer for SMC differentiation from stem cells, we investigated 
whether TGF-β1 signaling is one of the underlying mechanisms through which 
macrophage-derived MMP8 mediates SMC differentiation from AdSPCs. Indeed, we 
observed that SMC gene expression was significantly up-regulated by addition of 
recombinant activated TGF-β1 protein into MMP8_KO macrophage conditional 
culture medium, and the gene expression was further increased when TGF-β1 was 
added into the WT macrophage conditional medium (Figure 3A). Importantly, 
compared to cells treated with TGF-β1 and MMP8_KO macrophage conditional 
medium we observed a higher level of SMC gene expression in AdSPCs incubated 
with WT macrophage conditional medium alone (Figure 3A), suggesting additional 
signaling may also responsible for macrophage-derived MMP8 mediated SMC 
differentiation from AdSPCs. As expected, an opposite effect for SMC gene 
expression was observed when TGF-β1 was depleted from WT or MMP8_KO 
macrophage conditional culture medium using a neutralizing antibody (Figure 3B). 
Finally, the inhibitory effect of TGF-β1 depletion on SMC gene regulation was also 
mimicked by inhibiting TGF-β1 signal in WT macrophage conditional culture medium 
with a selective inhibitor SB431542 (Figure 3C). The above data suggest that 
macrophage-derived MMP8 promotes SMC differentiation from AdSPCs at least 
partially through modulating TGF-β1 signaling. 
 
ADAM10-Notch1 signaling pathway is activated by macrophage-derived MMP8 
during SMC differentiation from AdSPCs 
Our previous studies have shown that MMP8 promotes ADAM10 maturation by 
cleaving its prodomain39, 40. Moreover, it has been reported that ADAM10 is required 
for Notch1 site 2 cleavage and activation52, and that Notch1 and TGF-β1 signaling 
concomitantly regulate SMC differentiation during VSMC phenotype switching53. 
Furthermore, data from the previous section suggests additional signal pathway may 
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play a role in macrophage-derived MMP8 mediated SMC differentiation from AdSPCs. 
Therefore, we wondered if ADAM10-Notch1 signaling is another underlying 
mechanism of macrophage-derived MMP8 mediated SMC differentiation from 
AdSPCs. Immunofluorescence staining with an antibody against the prodomain of 
ADAM10 showed abundant ADAM10 containing its prodomain in AdSPCs incubated 
with MMP8_KO macrophage conditional culture medium (Figure 4A), indicating that 
the ADAM10 maturation and activity is inhibited in the absence of MMP8 in AdSPCs. 
Moreover, less activated Notch1 accumulated within the nuclei of AdSPCs treated 
with MMP8_KO macrophage conditional culture medium (Figure 4B), suggesting that 
the Notch1 signal is inhibited in AdSPCs when MMP8 protein was depleted from the 
culture system. Such inhibition was further confirmed in our luciferase activity assay 
using pGL2-4xCSL-luc (reporter for Notch signaling) (Figure 4C). Consistently, the 
Notch signaling was significantly activated by addition of the recombinant MMP8 and 
ADAM10 activated proteins into the culture system (Figure 4D and 4E). Taken 
together, the above data demonstrates that the ADAM10/Notch1 signal pathway is 
activated by macrophage-derived MMP8. 
 
The importance of ADAM10 in macrophage-derived MMP8 mediated SMC 
differentiation was further examined by using the ‘gain or loss of function’ experiments. 
Addition of activated ADAM10 protein into the WT or MMP8_KO macrophage 
conditional culture medium significantly up-regulated the expression levels of all the 
SMC genes examined (Figure 4F). As expected the highest SMC gene expression 
was observed when activated ADAM10 protein was added into WT macrophage 
conditional medium. Interestingly, we observed a higher level of SMC gene 
expression in AdSPCs incubated with WT macrophage conditional medium alone 
compared to cells treated with ADAM10 and MMP8_KO macrophage conditional 
medium (Figure 4F). Importantly, an opposite effect for SMC gene expression was 
observed when the endogenous ADAM10 in AdSPCs was inhibited by siRNA (Figure 
4G). Taken together, these data support an important role for ADAM10 in SMC 
differentiation from AdSPCs mediated by macrophage-derived MMP8. 
 
Notch1 promotes SMC differentiation from AdSPCs, and CSL binding site is 
required for Notch1-induced SMC gene expression  
To further explore the potential role of the Notch family in SMC differentiation from 
AdSPCs, the over-expression vectors for individual Notch (pCMV-flag-NICD1, 2, 3 
and 4) were introduced into MMP8_KO AdSPCs. We observed that over-expression 
of Notch1 (Figure 5A), but not other Notchs (Figure S7), significantly increased SMC 
related gene expression, indicating that Notch1 is the main Notch responsible for 
macrophage-derived MMP8 mediated SMC differentiation from AdSPCs. It has been 
well recognized that SRF/Myocardin complex and its corresponding DNA binding 
element CArG boxes within the promoter of SMC related genes is a central player in 
regulation of SMC gene expression and SMC differentiation from stem cells, we 
wondered if such a mechanism is behind Notch1-induced SMC gene regulation in 
AdSPCs. Data from luciferase activity assays, using the SMC gene promoter 
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reporters containing the native (pGL3-SMαA/SM22α-WT) or CArG mutated 
(pGL3-SMαA/SM22α-SRFmut) promoter DNA sequences of SMC genes, generated in 
our previous study47, showed that Notch1 significantly increased the WT gene 
promoter activity, and this was seen with the CArG mutated reporters as well(Figure 
5B and 5C), suggesting that Notch1-induced SMC gene expression is independent of 
SRF/Myocardin complex.  
 
Interestingly, a previous study has reported that SMαA is a direct target gene of 
Notch1, and human SMαA promoter contains a CSL consensus binding site 
(TGGGAA) beginning at ~64 from the translational starting site that is conserved in 
apes and rodents54. Indeed, after carefully searching the promoter sequences used 
for generating our mouse SMαA and SM22α gene reporters, we identified a DNA 
sequence, TGTGGGCA, which resembles but is not identical to the consensus 
binding site [(C/T)GTGGGAA] for CSL transcription factors, within both gene 
reporters. We therefore speculated that this DNA sequence serves as a functional 
CSL binding site. To confirm such a hypothesis, this sequence was mutated to 
generate CSL mutated gene reporters (pGL3-SMαA/SM22α-CSLmut). Luciferase data 
with these gene reporters showed that while over-expression of Notch1 in AdSPCs 
significantly increased the WT gene promoter activity, this was almost abolished 
when the CSL binding site was mutated (Figure 5D and 5E), revealing a dependence 
on this DNA element for Notch1-induced SMC gene expression. Finally, chromatin 
immunoprecipitation (ChIP) assays were conducted using a Flag antibody (NICD1) in 
the differentiating AdSPCs to further verify if Notch1 activates specific SMC gene 
transcription through its enrichment within SMC gene promoters. Data shown in 
Figure 5F and 5G revealed that NICD1 over-expression significantly increased its 
binding to the promoters of SMαA and SM22α. Taken together, the above findings 
demonstrate that Notch1 regulates SMαA and SM22α gene expressions during SMC 
differentiation from AdSPCs by increasing NICD1 enrichment within SMC gene 
promoters, and CSL binding site is required for SMC gene transcription regulated by 
Notch1.       
 
Macrophage-derived MMP8 promotes neointima formation in response to 
vascular injury  
Having established an important role for macrophage-derived MMP8 in SMC 
differentiation from AdSPCs, we further examined its involvement in arterial 
remodeling. To this end, we first examined the gene expression profiles during arterial 
remodeling in response to wire-induced vascular injury. Data shown in Figure 6A 
revealed that the gene expression level of SMαA was significantly decreased, while 
the macrophage gene CD68 along with MMP8 expression was dramatically 
increased during arterial remodeling induced by wire-injury. Importantly, compared to 
control arteries multiple AdSPC gene expression markers were significantly 
up-regulated following injury (Figure 6B). The increased expression of MMP8, CD68, 
Sox10 and Nestin in the injured arteries was further confirmed by immunostaining 
assays (Figure S8). Moreover, we observed MMP8 was mainly co-expressed with 
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CD68 in neointima (Figure S8). Furthermore, data shown in Figure S9 revealed that 
transplanted macrophages could migrate across the adventitia and media layer and 
infiltrate into intima, and that the transplanted macrophages was the major cellular 
source of MMP8 during arterial remodeling in response to injury. These data indicate 
that the AdSPCs are activated and infer an involvement for AdSPC activation and/or 
differentiation during arterial remodeling, consistent with previous findings8. These 
data also suggest a potential role for MMP8 derived from activated macrophages in 
injury-induced arterial remodeling. To investigate its role, vehicle (Matrigel) and 
BM-derived macrophages isolated from WT or MMP8_KO mice were perivascularly 
applied to carotid arteries immediately after injury similar to the protocol described in 
our previous studies48, 49, 55. Compared to WT macrophage transplantation, applying 
MMP8_KO macrophages onto the injured carotid arteries caused a significant 
decrease in the expression levels of SMC genes (SMαA, SM22α, h1-calponin and 
SM-myh11) and cell proliferation marker gene PCNA, but this had no apparent effect 
on the AdSPC gene expression examined in this study (Figure 6C). However, 
compared with vehicle control a trend of decreased expression of stem cell genes but 
a significant up-regulation of PCNA and SMC genes was observed in mice 
transplanted with either WT or MMP8_KO macrophages (Figure 6C). Importantly, we 
observed an increased amount of inactivated ADAM10 (Pro-ADAM10) (Figure 6D), 
but a decreased level of activated Notch1 staining in the injured carotid arteries 
transplanted with MMP8_KO macrophages (Figure 6E), compared with the injured 
carotid arteries treated with WT macrophages or vehicle control, indicating that the 
ADAM10-Notch1 signaling is inhibited in the injured vessels in the absence of 
macrophage-derived MMP8. Consequently, the injury-induced neointimal SMC 
hyperplasia was significantly increased in the carotid arteries transplanted with either 
WT or MMP8_KO macrophages. Importantly, when compared with the mice 
transplanted with WT macrophages a much smaller neointima size was observed in 
the mice received a MMP8_KO macrophage transplantation (Figure 6F and 6G), 
confirming a promotive effect of macrophages in neointimal lesion growth, and 
macrophage-derived MMP8 represents one of underlying mechanisms of 
macrophage-promoted neointimal SMC hyperplasia. 
 
 
Discussion 
The de-differentiation and proliferation of SMCs (SMC phenotype switching) has 
been widely established as the major contributor to vascular remodeling. However, 
increasing evidence2, 7, 8, 11-16 has also suggested an important involvement for a 
variety of vascular SPCs including AdSPCs, although the extent of their contribution 
remains to be elucidated and is source of great debate45, 56. There is a growing 
consensus that in response to injury, AdSPCs migrate into the intima, where they 
differentiate toward SMCs, contributing to neointimal lesion growth. However, the 
underlying molecular mechanisms of SMC differentiation from AdSPCs in the intima 
remains to be determined before we can target this cellular differentiation in order to 
prevent angioplasty-induced restenosis. In this study, we provide evidence to suggest 
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that macrophage-derived MMP8 is one of the driving forces behind SMC 
differentiation from AdSPCs and promotes neointimal SMC hyperplasia in response 
to injury. Macrophage-derived MMP8 exerts this function through activation of 
TGF-β1 signalling in parallel with the ADAM10/Notch1 signalling pathway (Figure 
6H).   
 
The reasons for selecting the MSC-like and Sox10/Nestin-positive AdSPCs, but not 
the Sca-1+ cells described in our previous studies57, 58 in this study are twofold. On the 
one hand, although we have successfully isolated adventitial Sca-1+ cells from mouse 
aortas and used them to validate the functional involvements of multiple SMC 
differentiation regulators, identified from our ES cell-SMC differentiation model, in 
SMC differentiation from vascular stem cells, we have found that the yield of the 
adventitia Sca-1+ cells is very limited and only allowed us to conduct a few small 
validation experiments. Moreover, we experienced enormous difficulties in 
maintaining them in an undifferentiated state. Stem cell properties were lost quickly 
during in vitro cell culture regardless of which stem cell maintenance culture medium 
was used and whether or not repeated cell sorting was applied to them. On the other 
hand, we obtained a much higher yield of MSC-like and Sox10/Nestin-positive 
AdSPCs (30-50 times higher than that of Sca-1+ cells from same amount of starting 
material), and found that culturing these AdSPCs is less laborious and time 
consuming. Importantly, these cells can be maintained in vitro for a long period (over 
10 passages, P10) without any significant loss of stem cell properties, as evidenced 
by almost all of them expressing high levels of MSC markers (such as Sox10 and 
Nestin), and exhibiting the potential to differentiate toward multiple cell lineages (Data 
not shown) including SMCs even at higher passages (P10). Moreover, new studies 
from Li’s group has elegantly demonstrated that Sox10+ MSCs can differentiate into 
SMCs to stabilize functional microvessels59, contribute to vascular pericytes/SMCs in 
most parts of the body60, and importantly established them as one of the cellular 
sources in the neointimal formation 61, suggesting that these AdSPCs are a good 
cellular model to study the underlying molecular mechanisms of SMC differentiation 
from adult vascular SPCs and their contribution to neointimal SMC hyperplasia.             
 
The importance of MMP8 in vascular diseases has been well-documented in several 
preclinical and clinical studies by others and our group, which has been nicely 
summarised in an elegant review41. Through a series of studies we have 
comprehensively demonstrated that MMP8 plays a causal role in atherosclerosis 
pathogenesis and progression as well as injury-induced neointima formation through 
multiple mechanisms. MMP8 can 1) convert Ang I to Ang II which in turn increases 
the expression of VCAM1 on ECs and enhances recruitment of leukocytes into the 
vascular wall, leading to vascular inflammation and atherosclerotic plaque formation 
and growth38; 2) promote atherosclerotic angiogenesis by up-regulation of 
platelet/endothelial cell adhesion molecule-1 in ECs62; 3) facilitate migration of 
BM_SPCs into the atherosclerotic lesions through its ability to degrade collagen I and 
to activate ADAM10 which in turn cleaves the intercellular protein E-cadherin that 
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mediates the interaction between BM_SPCs and its niche. After recruitement into 
atherosclerotic plaques, BM_SPCs can differentiate into inflammatory cells, further 
amplifying vascular wall inflammation and promoting atherosclerotic plaque growth40; 
4) control macrophage differentiation and polarisation through activation of TGF-β1 
signalling35; and 5) enhance SMC migration and proliferation through its ability to 
induce N-cadherin shedding by direct cleavage of N-cadherin ectodomains and/or via 
activating ADAM10 which in turn cleaves N-cadherin on SMCs. N-cadherin shedding 
from SMCs disrupts N-cadherin-mediated cell–cell adhesion and allows β-catenin to 
dissociate from cadherins and translocate into the nucleus, leading to SMC migration 
and proliferation. Increased SMC migration and proliferation contribute to neointimal 
SMC hyperplasia39. In this study, we reported another unrecognized role for MMP8 in 
SMC differentiation from AdSPCs, and further confirmed the functional importance of 
macrophage-derived MMP8 in vascular injury-induced neointimal SMC hyperplasia. 
Importantly, we found MMP8 regulates SMC differentiation through activation of the 
ADAM10/Notch1 signaling axis.  
 
Unlike BM-derived SPCs, we unexpectedly found that AdSPCs express little MMP8 
under physiological conditions, indicating these two SPCs are different from each 
other. This is certainly true in terms of their stem cell marker expression. The 
BM-derived SPCs express high levels of Sca-1 and c-Kit stem cell markers40, 
whereas the AdSPCs used in the current study are negative for both markers8. 
However, it would inappropriate to dismiss the functional involvement of MMP8 in 
SMC differentiation from AdSPCs, particularly in an in vivo disease setting, in which 
multiple cells (e.g., adventitia macrophages and AdSPCs) interact with and regulate 
each other’s functions through direct contact or in a paracrine manner. Indeed, we 
observed a significant increase in the numbers of macrophages but not the other 
MMP8 producing cells as well as AdSPCs within adventitia in response to injury. 
Moreover, it has been previously reported that macrophages control MSC 
differentiation towards SMCs in a paracrine fashion51. Furthermore, in our own 
previous study, we have demonstrated that MMP8 activates TGF-β1 signalling by 
increasing TGF-β production, as well as its bioavailability and biological activity in 
macrophages35. The above findings prompted us to hypothesize that 
macrophage-derived MMP8 may have a role in SMC differentiation. As expected, 
data from multiple experiments (macrophages-AdSPCs co-culturing, macrophage 
conditional culture medium, and MMP8 inhibition experiments using MMP8 
neutralizing antibody) showed us that macrophage-derived MMP8 has a promotive 
effect on SMC differentiation from AdSPCs. Importantly, the expression levels of 
macrophage, MMP8 and AdSPC marker genes were significantly up-regulated during 
injury-induced arterial remodeling. Therefore, we have speculated that in response to 
injury, both macrophages and AdSPCs within adventitia are activated. The activated 
and increased macrophages produce and secrete MMP8 into the stem cell niche, 
where it promotes AdSPC differentiation towards SMCs. However, it is worth 
mentioning that one of the limitations in this study is that our current data do not allow 
us to differentially interpret the effect of the perivascularly added macrophages from 
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the response of local macrophages, triggered by the vascular injury itself. Although 
we assumed that endogenous macrophages use the same mechanisms as 
transplanted ones, only additional data generated from the macrophage conditional 
knockout mice could address such a limitation.                 
 
Notch signaling is activated upon the binding of the corresponding Notch ligands to 
Notch receptors (Notch1-4), which in turn trigger two proteolytic cleavage events at 
the Notch receptor, catalyzed by the ADAM-family of metalloproteases and 
γ-secretase, respectively. Such cleavages releases the Notch intracellular domain 
(NICD) from plasma membrane, and allows it translocate to the nucleus, where they 
act as transcriptional coactivators to initiate down-stream signalling pathways63. Later 
studies confirmed the absolute requirement of ADAM10 for ligand-induced 
extracellular cleavage at site 2 (S2) of Notch152, 64. Importantly, both ADAM10 and 
Notch1 have been implicated in vascular development and diseases. ADAM10 has 
been reported to play a role in cell migration, adhesion, proliferation, survival, 
differentiation, angiogenesis, inflammation, and endothelium permeability through its 
capability to cleave many substrates with diverse function within the vasculature, 
such as Notch1, CD44, CD144, CX3CL1, CXCL16, VEGFRII, IL6R and TNFα65. 
Global deletion of the ADAM10 gene is embryonically lethal due to multiple cardiac 
and vascular defects similar to Notch1 mutants66. ADAM10 conditional knockout 
experiments demonstrate that EC ADAM10 controls organ-specific vascular 
development67, mainly through its regulator role in Notch1 signalling68. Apart from its 
developmental role in the cardiovascular system, a later study also suggested a 
causal role for myeloid ADAM10 in modulating atherosclerotic plaque stability69. In 
the current study, we have shown that macrophage-derived MMP8 promotes 
ADAM10 cleavage and maturation in AdSPCs, leading to Notch1 activation (Figure 
4A and 4B). Such a phenomenon was also observed in neointima cells during arterial 
remodelling (Figure 6D and 6E), indicating that macrophage-derived MMP8 
promotes neointimal SMC hyperplasia by activating ADAM10/Notch1 signaling. Our 
data is consistent with previous findings which showed increased ADAM10 
expression in coronary artery in-stent restenosis70.  
 
The importance of Notch signalling in VSMC behaviour and phenotype71, vascular 
development and diseases72, 73 has been extensively explored. High et al74 used 
Cre-lox technology to activate a dominant-negative inhibitor of Notch signalling 
specifically in the neural crest lineage, and found the resulting mice displayed cardiac 
outflow tract defects, mainly due to the inhibition of Notch genes as well as decreased 
SMC differentiation from neural crest precursors. Accordingly, Notch has been hailed 
as a ‘master regulator’ of vascular morphogenesis75. Later studies further confirmed 
that Notch activity is required for the differentiation of a Tie1+ local precursor to 
vascular SMCs in a spatiotemporal fashion across all vascular beds76, and that Notch 
activation in neural crest is required for SMC differentiation and aortic arch artery 
development77. Specifically, Notch1 was the predominant Notch receptor expressing 
in total and c-Kit+/NKX2.5+ BM-MSCs, and activation of Notch1 signalling contributed 
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to SMC differentiation of BM-MSCs78 and cardiac progenitor cells79. These findings 
are in alignment with our data showing that Notch1 (Figure 5), but not the other three 
Notchs (Figure S7), promotes SMC differentiation from AdSPCs, inferring a specific 
requirement for Notch1 in adult MSC differentiation toward SMCs. Apart from its 
critical role in vascular development, Notch1 has also been widely implicated in 
vascular disease. Particularly, Notch1 mutations have been widely reported in 
patients with bicuspid aortic valves and associated aortopathies such as ascending 
aortic aneurysm and aortic root dilation80, which has been further confirmed in mice 
with haploinsufficiency of Notch181, 82. Since inadequate arterial SMC repair capacity 
has been recognised as a fundamental underlying cause of aneurysm formation, it 
would be interesting to study if the MMP8/ADAM10/Notch1 signalling axis identified 
from the current study plays a positive role in this vascular disease through 
modulating SMC differentiation and phenotypes.  
 
It has been well established that the SRF-CArG interaction is a critical convergence 
point for signals that either activates SMC gene expression to promote SMC 
differentiation under physiological environments or represses SMC gene expression 
during pathophysiological conditions83. However, this mechanism is not responsible 
for Notch1-mediated SMC differentiation from AdSPCs as evidenced by Notch1 
over-expression in AdSPCs which could significantly increase the promoter activity of 
SMC genes with or without CArG binding sites to a similar extent (Figure 5B and 5C). 
Instead, we have now provided comprehensive evidence to suggest that both SMαA 
and SM22α are the direct transcriptional target genes of Notch1, and the DNA 
sequence (TGTGGGCA) which resembles but is not identical to CSL consensus 
binding site within SMαA and SM22α gene promoter acts as the functional binding 
site for Notch1/CSL transcriptional complex (Figure 5D-5G). Such an interaction 
between Notch1/CSL and the DNA motif is essential for Notch1-mediated SMC gene 
transcription during SMC differentiation from AdSPCs.  
 
In summary, although we provide no definitive evidence to discern the exact 
contribution of SMC differentiation from AdSPCs to intima formation in response to 
vascular injury, our study does show that macrophage-derived MMP8 plays a 
functional role in SMC differentiation from AdSPCs by activating both TGF-β1 and 
ADAM10/Notch1 pathways. Moreover, we also demonstrate that 
macrophage-derived MMP8 promotes vascular injury-induced neointimal SMC 
hyperplasia, partially through activation of ADAM10/Notch1 signaling axis. Thus, data 
from this study provides a new insight into the biological molecules and relevant 
mechanisms involved in SMC differentiation from AdSPCs particularly in the 
pathogenesis of post-angioplasty restenosis. 
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Figure Legends 
 
Figure 1. SMC differentiation from AdSPCs. 
 
AdSPCs (p3~p10) were cultured in SMC differentiation induction medium (DMEM 
supplemented with 5% FBS and 5ng/ml TGF-β1) for the indicated times. 
Undifferentiated AdSPCs were used as control (0d). Total RNAs and proteins were 
harvested and subjected to RT-qPCR (A, C and D), and Western Blot analyses (B), 
respectively. (A-B) SMC differentiation genes were significantly up-regulated in 
response to TGF-β1 treatment. (C) Activation of SMC-specific transcription factors 
during SMC differentiation. (D) Inhibition of AdSPCs specific genes. Data presented 
here are representative (B, left) or Mean±S.E.M  of six independent experiments, 
respectively (n=6). *P<0.05 (versus 0d, one-way ANOVA with a post hoc test of LSD). 
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Figure 2. An important role of macrophage-derived MMP8 in SMC differentiation 
from AdSPCs. 
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(A-C) AdSPCs (p3~p10) isolated from MMP8_KO mice were co-cultured (1:1) with 
bone marrow derived macrophages (BMMs) isolated from wild type (WT) and 
MMP8_KO mice for 48 hours. (D-F) MMP8_KO AdSPCs (p3~p10) were incubated 
with the conditioned culture medium (CM) from WT and MMP8_KO BMMs for 48 
hours. Total RNAs and proteins were harvested and subjected to RT-qPCR and 
Western Blot (C and F) analyses, respectively. (G) Inhibition of MMP8 causes a 
decreased expression of SMC genes. WT BMM CM was incubated with MMP8 
antibody or IgG control (1µg/ml) at 37ºC for 30 minutes. After then, BMM CM were 
used to induce SMC differentiation from MMP8_KO AdSPCs. (H) Activated MMP8 
protein increased SMC gene expression. MMP8_KO BMM CM contained 10ng/ml of 
activated MMP8 protein or vehicle was used to induce MMP8_KO AdSPC 
differentiation towards SMCs. Two days later, total RNAs were harvested and 
subjected to RT-qPCR analysis. Data presented here are representative (right panel 
in C and F) or Mean±S.E.M of five or six independent experiments, respectively (n=5 
or 6). *P<0.05 (versus WT-macrophage or CM:WT-macrophage, t-test). 
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Figure 3. TGF-β1 secreted by BMMs is responsible for MMP8-mediated SMC 
differentiation from AdSPCs. 
 
(A) Exogenous TGF-β1 protein increased SMC gene expression. WT or MMP8_KO 
BMMs conditioned culture medium (CM) contained 5ng/ml of activated TGF-β1 
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protein or vehicle was used to induce MMP8_KO AdSPC differentiation towards 
SMCs. (B) Depletion of TGF-β1 results in decreased expression of SMC genes. WT 
or MMP8_KO BMMs CM was incubated with TGF-β1 antibody or IgG control (1µg/ml) 
at 37ºC for 30 minutes. After then, the BMM CM was used to induce SMC 
differentiation from MMP8_KO AdSPCs. In (A & B), *P<0.05 (versus 
MMP8_KO/control or WT/IgG); #P<0.05 (versus MMP8_KO/TGFβ1 or WT/TGFβ1 
antibody); $P<0.05 (versus WT/control or MMP8_KO/IgG); one way ANOVA with a 
post hoc test of LSD. (C) SMC gene expressions were decreased by TGF-β1 
inhibition. MMP8_KO AdSPCs were incubated with WT BMMs CM in the presence or 
absence of 10 µM SB431542, a selective TGF-β1 inhibitor. Two days later, total RNAs 
were harvested and subjected to RT-qPCR analysis. *P<0.05 (versus control; t-test). 
Data presented here are Mean±S.E.M of six independent experiments (n=6).  
 
Figure 4. Importance of ADAM10-Notch1 signaling in macrophage-derived 
MMP8 mediated SMC differentiation from AdSPCs. 
 
(A and B) Increased pro-ADAM10 protein abundance, but reduced Notch1 nuclear 
translocation in MMP8_KO AdSPCs treated with MMP8_KO BMMs conditional 
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culture medium (CM). MMP8_KO AdSPCs were incubated with WT or MMP8_KO 
BMMs CM for two days. Cells were fixed and subjected to immunofluorescence 
staining with antibodies against the prodomain of ADAM10 (A) or activated Notch1 
(B). Representative images from three experiments (n=3) were presented here. (C-E) 
Luciferase activity assays to examine Notch signaling. MMP8_KO AdSPCs 
transfected with pGL2-4xCSL-luc reporter plasmid were incubated with CM from WT 
or MMP8_KO BMMs (C), or CM from MMP8_KO BMMs in the absence (vehicle) or 
presence of activated MMP8 (D)/ADAM10 (E) proteins, respectively. Two days later, 
total cell lysates were harvested and subjected to luciferase activity assays. (F) 
Activated ADAM10 protein increased SMC gene expression. CM from WT or 
MMP8_KO BMMs contained 10ng/ml of activated ADAM10 protein or vehicle was 
used to induce MMP8_KO AdSPC differentiation towards SMCs. (G) Knockdown of 
ADAM10 inhibits SMC gene expression. MMP8_KO AdSPCs transfected with control 
(si-NT) or ADAM10 (si-ADAM10) specific siRNA were incubated with CM from WT or 
MMP8_KO BMMs. Two days later, total RNAs were harvested and subjected to 
RT-qPCR analysis. Data presented here are representative (A & B) or Mean±S.E.M 
(C-G) of six independent experiments (n=6). In (C-E), *P<0.05 (versus 
CM:WT-macrophage, vehicle, control or control siRNA, t-test); in (F-G), *P<0.05 
(versus MMP8_KO/control or WT/si-NT); #P<0.05 (versus MMP8_KO/ADAM10 or 
WT/si-ADAM10); $P<0.05 (versus WT/control or MMP8_KO/si-NT); one way ANOVA 
with a post hoc test of LSD.     
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Figure 5. Notch1 promotes SMC differentiation from AdSPCs, and CSL binding 
site is required for Notch1-induced SMC gene expression. 
 
(A) Over-expression of activated Notch1 (NICD1) in MMP8_KO AdSPCs increases 
SMC gene expression. MMP8_KO AdSPCs transfected with control (pCMV-flag) or 
activated Notch1 over-expression (pCMV-flag-NICD1) plasmids were incubated with 
CM from MMP8_KO BMMs. Two days later, total RNAs were harvested and 
subjected to RT-qPCR analysis. (B and C) SRF binding site (CArG) is not required for 
Notch1-induced SMC gene transcription. MMP8_KO AdSPCs co-transfected with 
pCMV-flag or pCMV-flag-NICD1 and reporter plasmids harboring a native (WT) or 
CArG mutated (SRFmut) promoter DNA sequence of SMαA (B)/SM22α (C) gene as 
indicated in the figures were incubated with CM from MMP8_KO BMMs. (D and E) 
CSL binding site (TGTGGGCA) within SMC gene promoters is critical for 
Notch1-induced SMC gene transcription. MMP8_KO AdSPCs co-transfected with 
pCMV-flag or pCMV-flag-NICD1 and reporter plasmids harboring a native (WT) or 
CSL DNA binding motif mutated (CSLmut) promoter DNA sequence of SMαA 
(D)/SM22α (E) gene as indicated in the figures were incubated with CM from 
MMP8_KO BMMs. Two days later, total cell lysates were harvested and subjected to 
luciferase activity assays. (F and G) Notch1 over-expression increases its enrichment 
within SMC gene promoter. ChIP assays were performed using antibodies against 
Flag (NICD1) or normal IgG, respectively, as described in online supplemental data. 
PCR amplifications of the adjacent regions were included as additional control for 
specific promoter DNA enrichment. Data presented here are Mean±S.E.M of six 
independent experiments (n=6). *P<0.05 (versus pCMV-Flag; t-test).     
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Figure 6. Macrophage-derived MMP8 promotes injury-induced neointima SMC 
hyperplasia.  
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(A and B) Gene expression profiles during injury-induced arterial remodeling. Total 
RNAs were collected from uninjured/sham and injured carotid arteries at the indicated 
time points and subjected to RT-qPCR analyses. (C-G) Perivascular transplantation 
of macrophages and analysis. After balloon injury, 100µl of Matrigel containing vehicle 
or 106 bone marrow-derived macrophages (BMMs) per vessel per mice was 
immediately applied and packed around injured carotid arteries. Three days (C), 2 (D 
and E) or 4 weeks (F and G) later, injured segments of carotid arteries were 
harvested for analyses. (C) Perivascular transplantation of MMP8_KO BMMs 
decreased SMC and PCNA gene expression in injured arteries. Total RNAs were 
harvested from the injured arteries and subjected to RT-qPCR analyses with the 
indicated primers. The data presented in (A-C) are mean±S.E.M. of four independent 
experiments (3~5 carotid arteries were pooled for each experiment).  *P<0.05, 
**<0.01, ***<0.001 (versus uninjured vessels or Vehicle); #P<0.05 (versus WT); 
Kruskal-Wallis H test. (D and E) MMP8_KO BMMs transplantation inhibited 
ADAM10/Notch1 activation. Frozen sections from both groups (n=5 mice) were 
prepared and subjected to immunofluorescence staining with antibodies against the 
pro-peptide domain of ADAM10 (Pro-ADAM10, Abcam, ab39178) and activated 
Notch1 (Abcam, ab8925), respectively. Note: white arrow indicates the 
autofluorescence (green) of the internal elastic lamina. (F and G) Locally 
transplantation of MMP8_KO BMMs reduced neointima formation in wire-injured 
carotid arteries. Paraffin sections from vehicle (n=10) and two BMMs transplantation 
groups (n=12 mice) were proceed for H&E staining and morphometric analysis. 
Representative images (D-F) and morphological characteristics including media area, 
neointimal area and neointimal/media (N/M) ratio (G) at 28 days after injury were 
presented here. *P<0.05 (versus vehicle) and #P<0.05 (versus WT BMMs); one way 
ANOVA with a post hoc test of LSD. (H) Schematic illustration showing the model of 
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action for macrophage-derived MMP8 in SMC differentiation from AdSPCs and 
injury-induced neointima SMC hyperplasia. 
 
